CNR Institutional Research Information System

DI FIORE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.522
NA - Nord America 902
EU - Europa 391
SA - Sud America 299
AF - Africa 36
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 855
SG - Singapore 619
CN - Cina 363
BR - Brasile 243
HK - Hong Kong 150
VN - Vietnam 138
IT - Italia 116
FR - Francia 78
KR - Corea 65
NL - Olanda 42
JP - Giappone 38
IN - India 34
BD - Bangladesh 31
GB - Regno Unito 30
DE - Germania 27
AR - Argentina 24
FI - Finlandia 21
CA - Canada 17
MX - Messico 17
PL - Polonia 16
ID - Indonesia 15
IQ - Iraq 12
ZA - Sudafrica 11
RU - Federazione Russa 9
IL - Israele 8
CZ - Repubblica Ceca 7
EC - Ecuador 7
MA - Marocco 7
PK - Pakistan 6
SA - Arabia Saudita 6
VE - Venezuela 6
CO - Colombia 5
ES - Italia 5
KE - Kenya 5
PY - Paraguay 5
TR - Turchia 5
UA - Ucraina 5
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
IE - Irlanda 4
PE - Perù 4
SE - Svezia 4
UZ - Uzbekistan 4
AU - Australia 3
BG - Bulgaria 3
HU - Ungheria 3
JO - Giordania 3
LB - Libano 3
NP - Nepal 3
SV - El Salvador 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
LK - Sri Lanka 2
LT - Lituania 2
MN - Mongolia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 3.155
Salva come PNG Salva come JPEG
Città #
Singapore 369
Santa Clara 291
San Jose 171
Hong Kong 142
Hefei 137
Beijing 73
Seoul 65
Los Angeles 64
Lauterbourg 62
Ashburn 60
Hanoi 37
Dallas 36
Ho Chi Minh City 35
Naples 30
Tokyo 27
São Paulo 23
New York 20
Orem 17
Frankfurt am Main 14
Warsaw 13
Helsinki 10
Rio de Janeiro 10
Florence 9
Haiphong 9
Lappeenranta 9
Da Nang 8
Johannesburg 8
Minamishinagawa 8
Montreal 8
Bengaluru 7
Casandrino 7
Portsmouth 7
Amsterdam 6
Baghdad 6
Buenos Aires 6
Curitiba 6
Porto Alegre 6
Belo Horizonte 5
Boardman 5
Brooklyn 5
Buffalo 5
Chennai 5
Fortaleza 5
London 5
Mumbai 5
Nairobi 5
Rome 5
Valašské Meziříčí 5
Baku 4
Campinas 4
Dhaka 4
Dublin 4
Düsseldorf 4
Guarulhos 4
Mexico City 4
Milan 4
Phoenix 4
Stockholm 4
Tashkent 4
Toronto 4
Turin 4
Acalanes Ridge 3
Agra 3
Amman 3
Brasília 3
Casablanca 3
Charlotte 3
Hải Dương 3
Itu 3
Juiz de Fora 3
Lahore 3
Limeira 3
Manchester 3
Nha Trang 3
Ninh Bình 3
Poplar 3
Riyadh 3
San Salvador 3
Sofia 3
Sydney 3
Aarhus 2
Abidjan 2
Aguascalientes 2
Alghero 2
Ankara 2
Aracaju 2
Asunción 2
Athens 2
Barbacena 2
Bari 2
Blumenau 2
Bogotá 2
Bologna 2
Bragança Paulista 2
Brussels 2
Budapest 2
Caracas 2
Carney 2
Caxias do Sul 2
Cercola 2
Totale 2.020
Salva come PNG Salva come JPEG
Nome #
α-CAs from Photosynthetic Organisms 90
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 83
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. 79
Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII 77
Biochemical and Structural Insights into the Winged Helix Domain of P150, the Largest Subunit of the Chromatin Assembly Factor 1 69
Thermostable carbonic anhydrases in biotechnological applications 67
Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII. 65
Inhibition of the newly discovered ?-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with inorganic anions and small molecules 65
Structural study of the Carbonic Anhydrase SazCA from the thermophilic bacterium Sulfurihydrogenibium Azorense 64
Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors 62
Biochemical, structural, and computational studies of a ?-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei 62
ALPHA-CARBONIC ANHYDRASES 60
Human carbonic Anydrase VII protects cells from oxidative damage 59
X-Ray Crystallography of Carbonic Anhydrase Inhibitors and Its Importance in Drug Design 59
Faox enzymes inhibited Maillard reaction development during storage both in protein glucose model system and low lactose UHT milk. 58
Eta- and teta-carbonic anhydrase 57
Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase fromTrichomonas vaginalis 56
The crystal structures of 2-(4-benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide in complex with human carbonic anhydrase II and VII provide insights into selective CA inhibitor development 55
Interaction Studies between Carbonic Anhydrase and a Sulfonamide Inhibitor by Experimental and Theoretical Approaches 55
Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense 52
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl) benzenesulfonamide moiety 52
A NEW LEAD COMPOUND FOR THE DEVELOPMENT OF CARBONIC ANHYDRASE INHIBITORS 52
The Crystal Structure of a hCA VII Variant Provides Insights into the Molecular Determinants Responsible for Its Catalytic Behavior 51
Saccharomyces cerevesiae, Candida spp. and Cryptococcus neoformans β-CAs 51
The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies 50
Exploration of the residues modulating the catalytic features of human carbonic anhydrase XIII by a site-specific mutagenesis approach 49
Human Carbonic Anhydrases and Post-Translational Modifications: A Hidden World Possibly Affecting Protein Properties and Functions 49
Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity 48
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 47
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one 46
Post-translational modifications in tumor-associated carbonic anhydrases 44
Disclosing the interaction of carbonic anhydrase ix with cullin-associated nedd8-dissociated protein 1 by molecular modeling and integrated binding measurements. 42
Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? 41
X-ray structure of the first 'extremo-alfa-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 41
Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides 41
Protective Role of Carbonic Anhydrases III and VII in Cellular Defense Mechanisms upon Redox Unbalance 38
Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity 37
Fungal α-carbonic anhydrases 37
A new role of Human Carbonic Anhydrase VII in the protection of the cells from oxidative damage 36
Benzoxaborole as a new chemotype for carbonic anhydrase inhibition 36
Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II 35
Design, synthesis and characterization of peptides mimicking hCA IX IC tail able to interact with nuclear transport factors 35
Insights into the role of reactive sulfhydryl groups of Carbonic Anhydrase III and VII during oxidative damage 34
Crystal structure of the C183S/C217S mutant of human CA VII in complex with acetazolamide. 33
Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? 32
The zinc coordination pattern in the eta-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families 30
FAOX enzymes from Aspergillus sp as enzymatic tools for preventing AGE formation . In: 11th Maillard Reaction 30
CARBONIC ANHYDRASE INHIBITORS: X-RAY CRYSTALLOGRAPHIC STUDIES FOR THE BINDING OF MOLECULES CONTAINING A SULFAMIDE MOIETY 29
STRUCTURAL CHARACTERIZATION OF CARBONIC ANHYDRASE INHIBITORS INCORPORATING NEW METAL BINDING FUNCTIONALITIES 28
Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. 28
X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor 28
Biochemical and Structural Analysis of a New Carbonic Anhydrase from the Thermophilic Bacterium Sulfurihydrogenibium sp. YO3AOP1 27
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 27
STRUCTURAL AND INHIBITION STUDIES OF CARBONIC ANHYDRASE INHIBITORS CONTAINING THE SULFAMIDE ZINC BINDING GROUP 27
Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV. 27
Peptides mimicking IC tail of hCA IX tumor enzyme interact with nuclear transport factors 27
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity 26
Carbonic anhydraseinhibitors: X-ray crystallographic studies for the binding of N-substitutedbenzenesulfonamides to human isoform II 26
CARBONIC ANHYDRASE INHIBITORS: X-RAY CRYSTALLOGRAPHIC STUDIES FOR THE BINDING OF 5-AMINO-1,3,4-THIADIZOLE-2-SULFONAMIDE AND 5-(4-AMINO-3-CHLORO-5-FLUOROPHENYLSULFONAMIDO)-1,3,4-THIADIAZOLE-2-SULFONAMIDE TO HUMAN ISOFORM II 26
Hydroxylamine-O-sulfonamide is a versatile lead compound for the development of carbonic anhydrase inhibitors 26
Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II. 26
Hydrophobic Substituents of the Phenylmethylsulfamide Moiety Can Be Used for the Development of New Selective Carbonic Anhydrase Inhibitors 26
Biochemical characterization of CA IX, one of the most active Carbonic Anhydrase isozymes. 26
Carbonic Anhydrase VII 24
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents 24
Biochemical and Structural Analysis of a New Carbonic Anhydrase from the Thermophilic Bacterium Sulfurihydrogenibium sp. YO3AOP1 24
Crystal structure of the catalytic domain of the tumor-associated hCA IX 24
Recent developments of carbonic anhydrase inhibitors as potential drugs 23
NUCLEAR TRANSPORT FACTORS IMPORTIN KAPbeta2 AND EXPORTIN CRM1 INTERACT WITH THE TUMOR ENZYME hCA IX 22
Insights into the catalytic mechanism of the carbonic anhydrase family from the crystal structure of human isoform 22
Insights into the carbonic anhydrase family: biochemical characterization of the human isozyme VII 22
Structural analysis of BldR from Sulfolobus solfataricus provides insights into the molecular basis of transcriptional activation in Archaea by MarR family proteins 22
Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX 21
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors 21
Insights into the catalytic mechanism of the carbonic anhydrase family from the crystal structure of human isoform XIII 21
2-Substituted Estradiol Bis-sulfamates, Multitargeted Antitumor Agents: Synthesis, In Vitro SAR, Protein Crystallography, and In Vivo Activity 21
Human Carbonic Anhydrase VII protects cells from oxidative damage 20
Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: a structural overview 20
Structural characterization of human carbonic anhydrase VII. 20
Anticancer steroid sulfatase inhibitors: Synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography. 18
Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of Thr200 and Gln92 for obtaining tight-binding inhibitors. 18
Insights into Carbonic Anhydrase VII functional role 17
Totale 3.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.683
article - articoli 7.838
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 778
Totale 19.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 7 3 13 5
2024/20251.191 7 11 118 44 276 45 22 66 43 63 261 235
2025/20262.026 103 175 180 273 327 150 293 86 113 128 126 72
Totale 3.245